Search by Drug Name or NDC

    NDC 42291-0130-90 acarbose 25 mg/1 Details

    acarbose 25 mg/1

    acarbose is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is ACARBOSE.

    Product Information

    NDC 42291-0130
    Product ID 42291-130_0e1016e2-301c-0bec-e063-6294a90a6c87
    Associated GPIs 27500010000310
    GCN Sequence Number 036767
    GCN Sequence Number Description acarbose TABLET 25 MG ORAL
    HIC3 C4M
    HIC3 Description ANTIHYPERGLYCEMIC, ALPHA-GLUCOSIDASE INHIBITORS
    GCN 08070
    HICL Sequence Number 008283
    HICL Sequence Number Description ACARBOSE
    Brand/Generic Generic
    Proprietary Name acarbose
    Proprietary Name Suffix n/a
    Non-Proprietary Name acarbose
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name ACARBOSE
    Labeler Name AvKARE
    Pharmaceutical Class alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091343
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0130-90 (42291013090)

    NDC Package Code 42291-130-90
    Billing NDC 42291013090
    Package 90 TABLET in 1 BOTTLE (42291-130-90)
    Marketing Start Date 2013-12-24
    NDC Exclude Flag N
    Pricing Information N/A